Ensemble Therapeutics is focused on the discovery and development of breakthrough small molecule therapies for patients with cancer.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 12, 2004 | Series A | $15M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
ARCH Venture Partners | — | Series A |